From April 19 to 22, 2022, the Company accepted and passed the supervision and inspection of the production of Tetanus Vaccine, Adsorbed, Haemophilus Influenzae Type b Conjugate Vaccine and Group A and Group C Meningococcal Conjugate Vaccine by the inspection team organized by Sichuan Center for Food and Drug Evaluation, Inspection & Monitoring.

The inspection is detailed in the following table. Besides, no penalties were made against the Company’s products due to quality since their launch.